INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,706 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
SH
Shlomi Ben HaimDirector, CHIEF EXECUTIVE OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$27K
300 sh
Aug 7, 2026Aug 11, 2026
Page 532 of 1693
← PrevNext →
traded Aug 7, 2026
+4d
SEC Form 4

Evidence

8
KM
Kluppel Ann MSVP and Controller
PSXPhillips 66
Option exercise
M$211K
2,100 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

7
Robinhood Markets, Inc.10% Owner
RVIRobinhood Ventures Fund I
Open-market sale · 10b5-1 plan
SELL$273K
9,764 sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC Form 4

Evidence

7
PH
Perkins Abigail HChief Information Officer
SNEXStoneX Group Inc.
Open-market sale · 10b5-1 plan
SELL$292K
4,500 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

7
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Option exercise · 10b5-1 plan
M—
2,950 sh
Aug 8, 2026Aug 11, 2026
traded Aug 8, 2026
+3dSEC Form 4

Evidence

6
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Open-market sale · 10b5-1 plan
SELL$6,704
1,117 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

5
GD
Gizinski DanielPresident, S&S Comm. Segment
CMTLCOMTECH TELECOMMUNICATIONS CORP /DE/
Option exercise
M—
280 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

5
GD
Gizinski DanielPresident, S&S Comm. Segment
CMTLCOMTECH TELECOMMUNICATIONS CORP /DE/
Tax withholding
F$218
127 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

5
LM
Long Darren MarcVice President
CGNXCOGNEX CORP
Option exercise
M—
2,500 sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC Form 4

Evidence

5
TK
Truong KristinaChief Accounting Officer
ENVXEnovix Corp
Tax withholding
F$1,174
253 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

5
RH
Rubenstein Andrew H.Director, 10% Owner, Chairman
ACELAccel Entertainment, Inc.
Grant or award
A—
335.5K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

5
GD
Gizinski DanielPresident, S&S Comm. Segment
CMTLCOMTECH TELECOMMUNICATIONS CORP /DE/
Option exercise
M—
280 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

5
KR
Krawczyk Joseph R IISR. CORP VP, WW CLIENT ENGMT
MCHPMICROCHIP TECHNOLOGY INC
Grant or award
A—
302 sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC Form 4

Evidence

5
RH
Rubenstein Andrew H.Director, 10% Owner, Chairman
ACELAccel Entertainment, Inc.
Option exercise
M—
346.8K sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC Form 4

Evidence

5
RH
Rubenstein Andrew H.Director, 10% Owner, Chairman
ACELAccel Entertainment, Inc.
Disposition to issuer
D—
173.4K sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC Form 4

Evidence

5
WM
Wensveen MaartenEVP & Chief Technology Officer
CMPRCIMPRESS plc
Grant or award
A—
46.7K sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC Form 4

Evidence

5
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Other acquisition or disposition
J—
10.4K sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC Form 4

Evidence

5
BB
Bunker Mathew BSR CORPORATE VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Grant or award
A—
280 sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC Form 4

Evidence

5
LP
Lee Anthony PDirector
RBLXRoblox Corp
Gift
G—
100.0K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

5
Xu TonyDirector, CHIEF EXECUTIVE OFFICER, 10% Owner
DASHDoorDash, Inc.
Other acquisition or disposition
J—
8,159 sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC Form 4

Evidence

4
Robinhood Markets, Inc.10% Owner
RVIRobinhood Ventures Fund I
Open-market sale · 10b5-1 plan
SELL$185K
6,577 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

4
CK
Clark KyleDirector, SEE REMARKS
BETABETA Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$416K
17.0K sh
Aug 11, 2026Aug 11, 2026
traded Aug 11, 2026
+0dSEC Form 4

Evidence

4
CK
Clark KyleDirector, SEE REMARKS
BETABETA Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$349K
15.0K sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC Form 4

Evidence

4
CK
Clark KyleDirector, SEE REMARKS
BETABETA Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$385K
15.9K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

4
Robinhood Markets, Inc.10% Owner
RVIRobinhood Ventures Fund I
Open-market sale · 10b5-1 plan
SELL$58K
2,024 sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC Form 4

Evidence

3
BN
Baruch NiranChief Financial Officer
AUDCAUDIOCODES LTD
Open-market sale · 10b5-1 plan
SELL$19K
1,875 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

3
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M—
3,833 sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC Form 4

Evidence

3
AL
Aldema LiorEVP and Chief Business Officer
AUDCAUDIOCODES LTD
Open-market sale · 10b5-1 plan
SELL$28K
2,812 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

3
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M—
16.2K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

2
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M$69K
3,833 sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC Form 4

Evidence

2
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Option exercise
M—
35.4K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

2
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Option exercise
M—
28.2K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

1
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M$289K
16.2K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

0
PH
Perkins Abigail HChief Information Officer
SNEXStoneX Group Inc.
Option exercise · 10b5-1 plan
M—
4,500 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

0
MA
McGeorge AnneDirector
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M$24K
1,250 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

0
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M$113K
2,520 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

0
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M—
2,520 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

0
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Option exercise · 10b5-1 plan
M—
2,950 sh
Aug 8, 2026Aug 11, 2026
traded Aug 8, 2026
+3dSEC Form 4

Evidence

0
MA
McGeorge AnneDirector
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M—
1,250 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence

0
MA
McGeorge AnneDirector
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M—
6,500 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC Form 4

Evidence